• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Characteristics of Transfusion Recipients in the United States

November 29, 2017

The Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) has gathered detailed information on both inpatient and outpatient transfusions over the past 6 years in the United States. Data from a two year period (2013-14) collected from 12 U.S. hospitals in four regions among inpatients was recently published in Transfusion.  Based on 641,751 inpatients, 12.5% (80,362) received a transfusion—the majority were transfused with RBCs (10.9%).  Platelet and plasma transfusions occurred less frequently (3.2% and 2.9%, respectively).  Almost one half (47%) of all transfused units were issued in the general wards; 25.7% of units were used in the ICU and 19.8% in the operating room.  The mean hemoglobin level for transfused patients was 7.6 g/dL, which is consistent with restrictive transfusion approaches.  Patient mortality with regard to transfusions increased with age, number of units transfused, and the use of platelets or plasma.  Febrile non-hemolytic reactions were the most commonly reported adverse events.  Large, comprehensive databases such as the REDS-III are a valuable resource that researchers can utilize to help make transfusions safer for patients.

Reference:

  1. Karafin MS, Bruhn R, Westlake M, et al. Demographic and epidemiologic characterization of transfusion from four US regions: evidence from the REDS-III recipient database. Transfusion 2017; online doi:10.1111/trf.14370

Filed Under

  • CME
  • News
  • RBC Transfusion

Recommended

  • Fibrinogen Concentrate Is Equivalent to Cryoprecipitate for Bleeding after Cardiac Surgery

  • High-throughput Blood Antigen Array Genotyping for Blood Donors

  • Blood Donation Intervals Should Be Extended to 180 Days To Avoid Iron Deficiency

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • RBCs with Reduced Deformability are Removed from Circulation

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley